U.S. senators on Friday called for Medicare to offer broad coverage of Alzheimer’s treatments approved by the Food and Drug Administration, warning that current restrictions cost patients precio...
Tag: Eisai Co Ltd
Maker of Alzheimer drug Leqembi expects FDA’s full approval this summer
Tek Image/science Photo Library | Science Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this s...
Biogen, Thor Industries, Lyft and more
Check out the companies making headlines before the bell: Biogen (BIIB) – Biogen soared 45.6% in premarket trading after Biogen and Japanese partner Eisai said their experimental Alzheimer’s dru...
Why Biogen’s Alzheimer’s drug Aduhelm is so controversial
The U.S. Food and Drug Administration’s approval of Biogen’s Alzheimer’s drug Aduhelm in June was heralded as a historic triumph in the fight against a disease that kills thousands o...